Bioprocess Containers Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

Bioprocess Containers Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The bioprocess containers market is anticipated to grow at a CAGR of 12.2% over the forecast period of 2022-2027.

Initially, the emergence of the COVID-19 pandemic had a significant impact on the bioprocess containers market because lockdown all over the globe affected the supply chain of instruments, raw materials, and other necessary products but research and development activities came into focus for the development of a vaccine against COVID-19 and there was a huge investment by the various private as well and government entities in the area for the vaccines which is expected to have a very significant impact on the market because bioprocess containers play a very crucial role in the vaccine development and production. For instance, according to an article published in July 2021, titled “COVID-19 Vaccine R&D Investments”, the public sector and Coalition for Epidemic Preparedness Innovations (CEPI) invested USD 5.6 billion in developing COVID-19 vaccines and about USD 51.1 billion was spent on advanced purchase agreements (APAs). Hence, the COVID-19 pandemic is expected to have a significant impact on the bioprocess containers market.

The major factors attributing to the market's growth are the rise in the global prevalence of cancer and immunological disorder cases that necessitate the requirement for vaccines and biologics coupled with the increased preference for immunotherapy and chemotherapy fuels the demand for bioprocess containers. For instance, according to the April 2022 report of the American Cancer Society, biologics are used in the treatment of cancer in many ways and are being used widely for the treatment.

Additionally, in August 2022, Innovent Biologics of China and Paris-based Sanofi would invest USD 2.42 billion in the biopharma group to jointly develop two cancer drugs in China. As per the Innovent Biologics, SAR408701, or tusamitamab ravtansine, would be used to treat lung, gastric and other cancers, while SAR444245, or non-alpha IL-2, was under phase-II studies for skin cancer, head, and neck tumors, among others. Hence, with the growing burden of cancer and funding in therapeutics development is expected to boost growth in the studied market.

In addition to this, the other business expansion initiative by the companies in the area such as expansion, mergers, acquisitions, and collaborations are further expected to fuel growth in the bioprocess containers market over the forecast period. For instance, in June 2022, the Rare Disease division of AstraZeneca, Alexion, will spend about EUR 65 million to expand its manufacturing capabilities in Ireland, and over the next 18 months, the investment will be used by the company to build up its biologics manufacturing capacity and increase research and development initiatives in the country. Hence, owing to the above-mentioned factors, the demand for bioprocess containers is expected to increase over the forecast period and the market is expected to grow.

Furthermore, vaccines are one of the most important forms of biologics that are used in the treatment of various medical conditions, and the companies are investing heavily in the development of vaccines for many diseases including rare ones which are further expected to boost the market growth. For instance, in October 2021, the Swedish investment company, Flerie Invest, made an investment of USD 52 million to establish an innovation hub for advanced vaccines and biological drugs in Matfors in northern Sweden. Moreover, the growing burden of chronic diseases is expected to be a significant factor fueling growth in the bioprocess containers market over the forecast period. Therefore, due to the above-mentioned factors, the bioprocess containers market is expected to grow over the forecast period. However, the high cost associated with the equipment coupled with impurity issues related to leachable and extractable and strict regulatory regulations is expected to restrain the growth of the bioprocess containers market during the forecast period.

Key Market Trends2D Bioprocess Containers Segment is Expected to Hold the Major Market Share in the Market Over the Forecast Period

The 2D bioprocess containers segment is anticipated to hold a significant share in the studied market due to their capacity to expedite the existing biopharmaceutical production process and the fact that they are useful for media preparation, fluid management, and storage of the produce. For cell harvesting and the delivery of bulk drug products and bulk drug precursors, 2D bioprocess containers are used widely, and hence, with the investment in the development and expansion of biologics production, the demand for 2D bioprocess containers is expected to increase which is anticipated to boost segment’s growth. There are several companies that offer advanced 2D bioprocess containers such as Thermo Fisher, CellBios, and Cole-Palmer among others.

The rising investment in the development and production of more biologics is compelling the bioprocess container manufacturers to enhance their offering and expand their capacity which is expected to have a positive impact on the 2D bioprocess containers segment. For instance, in December 2020, Thermo Fisher expanded its Utah bioprocess container site with the addition of 20,000 square feet of clean room space, and with the completion of the expansion, the company is expected to increase its manufacturing capacity of 2D and 3D bioprocessing container chambers by 70%. Such company investments are expected to further accelerate the market growth during the forecast period. Therefore, due to the aforementioned factors, the 2D bioprocess containers segment is expected to hold a significant market share over the forecast period.

North America Region is Expected to Occupy a Major Market Share in the Market Over the Forecast Period

The North American region is home to some of the largest pharmaceuticals and biopharmaceutical companies that are actively engaged in biologics development and production. Other factors that are expected to boost market growth are the high demand for biopharmaceutical products owing to the high burden of chronic diseases and government initiatives. For instance, in May 2021, Quebec became the fourth Canadian province to implement a mandatory biosimilar switching program and with some exceptions, the province is switching to a policy of allowing only biosimilars, if available, on lists of approved biologics. Hence, initiatives like these promoting the adoption of biologics are expected to have a significant impact on the bioprocess containers market and fuel growth in the market.

In the North American region, the United States is expected to hold a very significant market share in the bioprocess containers market owing to the huge investment in biologics and high number of biologics approval in the country coupled with the rising burden of chronic diseases. For instance, in July 2021, Cytiva and Pall Corporation, have planned to invest about USD 1.5 billion over two years to expand their capacity to meet the growing demand for biotechnology products. As per the press release by Cytiva, over USD 600 million would be invested for chromatography resins, over USD 400 million in cell culture media, over USD 300 million in single-use technology for example bioreactors, and over USD 200 million for the expansion of their sites across China and the rest of the Asia-Pacific region, Europe, and the United States. Similarly, in April 2022, Catalent revealed its plan to invest about USD 350 million at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across various modalities with new bioreactors, syringe filling lines, and additional lyophilization capacity, supported by quality control laboratories and complex automated packaging. Therefore, due to the above-mentioned factors, the North American region is expected to hold a major share in the bioprocess containers market, with the United States being a major market for bioprocess containers over the forecast period.

Competitive Landscape

The global bioprocess containers market is moderately competitive and consists of several major players. Some prominent players currently dominating the market in terms of market share are acquiring the products, entering into partnerships with other companies to consolidate their market positions across the globe, and others are distributing and launching new products. Some of the companies which are currently dominating the market are Thermo Fisher Scientific Inc, Danaher Corporation (Cytiva), Saint-Gobain S.A, Lonza Group AG, and Avantor Inc

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.